Literature DB >> 4554232

Anti-tumor immunoreactivity in patients with malignant melanoma.

R C Nairn, A P Nind, E P Guli, D J Davies, J H Little, N C Davis, R H Whitehead.   

Abstract

Entities:  

Mesh:

Year:  1972        PMID: 4554232

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  15 in total

1.  Lymphocyte stimulation in the cellular inflammatory reaction of some human skin tumours.

Authors:  H Pullmann; G K Steigleder
Journal:  Arch Dermatol Res       Date:  1975-10-29       Impact factor: 3.017

Review 2.  The role of immunotherapy in the management of patients with malignant melanoma.

Authors:  J E Goodnight; D L Morton
Journal:  World J Surg       Date:  1979-07-30       Impact factor: 3.352

3.  [Comparative autoradiographic study on the stroma reaction in melanoma and basal cell epithelioma (author's transl)].

Authors:  H Pullmann; G K Steigleder
Journal:  Arch Dermatol Forsch       Date:  1974

4.  A study of cellular inflammatory reaction in human malignant melanoma, using in vitro-labelling techniques with h3-thymidine.

Authors:  H Pullmann; G K Steigleder
Journal:  Arch Dermatol Forsch       Date:  1974-04-29

5.  Immunosuppresive effect of a human hepatic glycoferroprotein, alpha2H globulin. A study on the transformation of normal human lymphocytes.

Authors:  D Buffe; C Rimbaut
Journal:  Immunology       Date:  1975-07       Impact factor: 7.397

6.  Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells.

Authors:  T E Carey; T Takahashi; L A Resnick; H F Oettgen; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

7.  Immune response to a syngeneic rat tumour: development of regional node lymphocyte anergy.

Authors:  G R Flannery; P J Chalmers; J M Rolland; R C Nairn
Journal:  Br J Cancer       Date:  1973-08       Impact factor: 7.640

8.  Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens.

Authors:  H Shiku; T Takahashi; H F Oettgen
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

9.  Anti-tumour immunity in malignant melanoma assay by tube leucocyte adherence inhibition.

Authors:  J H Marti; D M Thomson
Journal:  Br J Cancer       Date:  1976-08       Impact factor: 7.640

10.  Lymphocyte anergy in patients with carcinoma.

Authors:  A P Nind; R C Nairn; J M Rolland; E P Guli; E S Hughes
Journal:  Br J Cancer       Date:  1973-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.